Malaria and Sickle Cell Disease Treatment Market Size and Forecasts (2020-2030)

According to our latest study on ” Malaria and Sickle Cell Disease Treatment Market Forecast to 2030 – Global Analysis –Treatment, Route of Administration, and Distribution Channel,” the market is expected to grow from US$ 4.691 billion in 2022 to US$ 29.179 billion by 2030; it is estimated to grow at a CAGR of 26.5% during 2022–2030. The market growth is primarily attributed to increasing prevalence of malaria and sickle cell disease and rising government initiatives to raise awareness about malaria and SCD. However, lack of sickle cell disease treatment options and the availability of counterfeit antimalarial drugs, followed by subsequent drug resistance are hindering the market growth.

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial and SCD drug/vaccine pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria and sickle cell disease. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

A few antimalarial and SCD drugs/vaccines that are under clinical development are mentioned in the table below:

Table 1. Malaria Drugs/Vaccine/Compounds Under Clinical Development

Drug Developer Clinical Trial Stage

Artefenomel Sanofi Phase IIb

KAE609 Novartis AG Phase IIb

KAF156 Novartis AG Phase IIb

DSM265 Takeda Pharmaceutical Company Phase IIa

SANARIA PfSPZ-GA1 Sanaria Phase II

SANARIA PfSPZ Vaccine – Radiation Attenuated PfSPZ Vaccine Sanaria Phase II

SANARIA PfSPZ-CVac Sanaria Phase II

MSP3-CRM-Vac4All Vac4All Phase I

Liver-Stage Antigen-3 (LSA3) Vac4All Phase IIa

Source: Company Website, the research team Analysis

Table 2. Sickle Cell Disease Drugs/Vaccine/Compounds Under Clinical Development

Drug Developer Clinical Trial Stage

Inclacumab Pfizer Phase III

Voxelotor Pfizer Phase III

GBT021601 Pfizer Phase II

PF-07209326 Pfizer Phase II

RG6107 Roche Phase II

GSK4172239D GSK Phase I

BEAM¬–101 Beam Therapeutics Phase I/II

HGB-206 Bluebird Bio, Inc. Phase I/II

HGB-210 Bluebird Bio, Inc. Phase III

ALXN1820 Alexion Phase II

NCT05714969 Takeda Pharmaceutical Company Limited Phase 2b

NCT03997760 Takeda Pharmaceutical Company Limited Phase I

Source: Company Website, the research team Analysis

Therefore, the growing number of antimalarial and SCD drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

Increasing Prevalence of Malaria and Sickle Cell Disease to Bolster Malaria and Sickle Cell Disease Treatment Market Growth

Malaria, one of the acute febrile illnesses, is caused by plasmodium parasites and spreads through the infected female Anopheles mosquitoes. Five parasite species in humans mainly cause malaria, and two of these species—Plasmodium falciparum and P. vivax—are considered the greatest threat to human health. Also, P. falciparum is the deadliest malarial parasite, and it is most widely spread across the African continent. Further, P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO’s methodology for calculating malaria mortality (irrespective of COVID-19 disruptions).

The WHO African region accounted for a high share of the global burden of malaria. In 2020, ~95% of global cases and ~96% of deaths were reported in Africa due to malaria, and ~80% of the total deaths that were reported were in children aged 5 and below. According to the WHO, four African countries, Nigeria, Tanzania, the Democratic Republic of the Congo, and Mozambique, recorded approximately half of all malaria-related deaths that were reported globally. According to the LANCET Regional Health 2020, African countries had the highest burden of malaria; P. falciparum is a notable cause of the highest mortality rates in children younger than 5, which accounts for ∼77% across the world; in African countries, P. falciparum accounts for ∼96% of total mortalities caused among children by malaria. P. vivax has been a causal agent of 2% (4.5 million) of the total cases of malaria, mainly from Asia. According to WMR 2021, ∼2% of the global burden of malaria was recorded by Southeast Asian countries, where India accounted for 83% of estimated malaria cases and 82% of deaths associate with malaria in 2020.

The treatment plan for sickle cell disease (SCD) can be divided into two categories: maintaining health and treating complications. Sickle cell anemia has genotypic and phenotypic variants that are based on unique mutations in hemoglobin genes. There is a high prevalence of the disease as well as a rise in its severity across the globe. According to the WHO, approximately 5% of the world’s population has genes inhibiting hemoglobin diseases such as sickle cell anemia and thalassemia. According to a study on sickle cell disease published in the National Library of Medicine, more than 300,000 babies are born with severe hemoglobin disorders each year; also, 400,000 newborns are expected to have sickle cell disease by 2050. In addition, according to a published report in 2023 by the American Society of Hematology, the estimated number of people suffering from SCD in the US is approximately 70,000–100,000. Thus, the rising prevalence of malaria and sickle cell disease in different regions across the globe boosts the malaria and sickle cell disease treatment market growth.

Cipla Ltd, Pfizer Inc, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, Emmaus Life Sciences Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, and Lupin Ltd are among the leading companies operating in the malaria and sickle cell disease treatment market.

Malaria and Sickle Cell Disease Treatment Market, by Region, 2022 (%)

Source: the research team Analysis

Based on treatment, the sickle cell disease treatment market is segmented into malaria and sickle cell disease (SCD). Based on route of administration, the sickle cell disease treatment market is bifurcated into oral and parenteral. Based on distribution channel, the sickle cell disease treatment market is divided into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the sickle cell disease treatment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, Nigeria, Congo, Tanzania, Uganda, Ghana, Kenya, Zambia, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights – Malaria
2.2 Key Insights – Sickle Cell Disease
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Malaria and Sickle Cell Disease Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis – Malaria Treatment
4.3 PEST Analysis – Sickle Cell Disease Treatment
5. Malaria and Sickle Cell Disease Treatment Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Prevalence of Malaria and Sickle Cell Disease
5.1.2 Rising Initiatives to Raise Awareness about Malaria and SCD
5.2 Market Restraints
5.2.1 Lack of Sickle Cell Disease Treatment Options and Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Growing Strategic Initiatives by Market Players
5.4 Future Trends
5.4.1 Extending Pipeline of New Drugs and Vaccines
5.5 Impact Analysis
6. Malaria and Sickle Cell Disease Treatment Market – Global Market Analysis
6.1 Malaria Treatment Market Revenue (US$ million), 2022 – 2030
6.2 Sickle Cell Disease Treatment Market Revenue (US$ million), 2022 – 2030
6.3 Geography Analysis Market Revenue (US$ million), 2022 – 2030
6.4 Epidemiology Data for Malaria
6.4.1 Malaria Transmission Characteristics, Immunity, and Clinical Features
6.4.2 Estimated Malaria Cases and Deaths
6.4.2.1 Fundings for Malaria-Related R&D, 2021
6.4.2.2 Fundings for Malaria Control, 2021
6.5 Funding Allocation Mechanism
6.5.1 Global Funds
6.5.1.1 USAID: Burundi-Malaria Operational Plan FY 2022
6.5.1.2 Procurement Scenario For Malaria Drugs
6.6 Reimbursement Scenario for Malaria
6.6.1 Overview
6.7 Sickle Cell Disease
6.7.1.1 Epidemiology Data of Sickle Cell Disease (SCD), 2020
6.8 Fundings for Sickle Cell Disease (SCD)
6.9 Reimbursement Scenario for Sickle Cell Disease
6.9.1 Overview
6.10 Number of Healthcare Facilities and Healthcare Expenditure:
7. Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 Overview
7.4 Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.5 Malaria
7.5.1 Overview
7.5.2 Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Malaria Treatment Market, by Treatment
7.6 Sickle Cell Disease (SCD)
7.6.1 Overview
7.6.2 Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Sickle Cell Disease Treatment Market, by Treatment
8. Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Overview
8.4 Sickle Cell Disease Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.5 Oral
8.5.1 Overview
8.5.2 Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.5.3 Oral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Parenteral
8.6.1 Overview
8.6.2 Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.6.3 Parenteral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Overview
9.4 Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.5 Direct Tender
9.5.1 Overview
9.5.2 Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3 Direct Tender: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Hospital Pharmacies
9.6.1 Overview
9.6.2 Hospital Pharmacies: Malaria Market – Revenue and Forecast to 2030 (US$ Million)
9.6.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
9.6.3 Hospital Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.6.3.1.1 Sickle Cell Disease Treatment Market, by Hospital Pharmacies
9.7 Retail Pharmacies
9.7.1 Overview
9.7.2 Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.7.2.1.1 Malaria Treatment Market, by Retail Pharmacies
9.7.3 Retail Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.7.3.1.1 Sickle Cell Disease Treatment Market, by Retail Pharmacies
9.8 Online Pharmacies
9.8.1 Overview
9.8.2 Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.8.3 Online Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others : Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.9.3 Others: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Malaria and Sickle Cell Disease Treatment Market – Geographical Analysis
10.1 North America Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.1 North America: Malaria Treatment Market, by Treatment
10.1.3.2 North America: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.3 North America: Malaria Treatment Market, by Route of Administration
10.1.3.4 North America: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.5 North America: Malaria Treatment Market, by Distribution Channel
10.1.3.5.1 North America: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.5.2 North America: Malaria Treatment Market, by Retail Pharmacies
10.1.3.6 North America: Sickle Cell Treatment Market, by Distribution Channel
10.1.3.6.1 North America: Sickle Cell Treatment Market, by Hospital Pharmacies
10.1.3.6.2 North America: Sickle Cell Treatment Market, by Retail Pharmacies
10.1.3.7 North America: Malaria Treatment Market, by Country
10.1.3.8 North America: Sickle Cell Disease Treatment Market, by Country
10.1.3.9 US
10.1.3.10 Overview
10.1.3.10.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.10.2 US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.10.3 US: Malaria Treatment Market, by Treatment
10.1.3.10.4 US: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.10.5 US: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.10.6 US: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.10.7 US: Malaria Treatment Market, by Distribution Channel
10.1.3.10.7.1 US: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.10.7.2 US: Malaria Treatment Market, by Retail Pharmacies
10.1.3.10.8 US: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.10.8.1 US: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.10.8.2 US: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.1.3.11 Canada
10.1.3.12 Overview
10.1.3.12.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.12.2 Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.12.3 Canada: Malaria Treatment Market, by Treatment
10.1.3.12.4 Canada: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.12.5 Canada: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.12.6 Canada: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.12.7 Canada: Malaria Treatment Market, by Distribution Channel
10.1.3.12.7.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.12.7.2 Canada: Malaria Treatment Market, by Retail Pharmacies
10.1.3.12.8 Canada: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.12.8.1 Canada: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.12.8.2 Canada: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.1.3.13 Mexico
10.1.3.14 Overview
10.1.3.14.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.14.2 Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.14.3 Mexico: Malaria Treatment Market, by Treatment
10.1.3.14.4 Mexico: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.14.5 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.14.6 Mexico: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.14.7 Mexico: Malaria Treatment Market, by Distribution Channel
10.1.3.14.7.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.14.7.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
10.1.3.14.8 Mexico: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.14.8.1 Mexico: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.14.8.2 Mexico: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2 Europe Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.2.1 Overview
10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.1 Europe: Malaria Treatment Market, by Treatment
10.2.3.2 Europe: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.3 Europe: Malaria Treatment Market, by Route of Administration
10.2.3.4 Europe: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.5 Europe: Malaria Treatment Market, by Distribution Channel
10.2.3.5.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.5.2 Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.3.6 Europe: Sickle Cell Treatment Market, by Distribution Channel
10.2.3.6.1 Europe: Sickle Cell Treatment Market, by Hospital Pharmacies
10.2.3.6.2 Europe: Sickle Cell Treatment Market, by Retail Pharmacies
10.2.3.7 Europe: Malaria Treatment Market, by Countries
10.2.3.8 Europe: Sickle Cell Disease Treatment Market, by Countries
10.2.3.9 France
10.2.3.10 Overview
10.2.3.10.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.10.2 France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.10.3 France: Malaria Treatment Market, by Treatment
10.2.3.10.4 France: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.10.5 France: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.10.6 France: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.10.7 France: Malaria Treatment Market, by Distribution Channel
10.2.3.10.7.1 France: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.10.7.2 France: Malaria Treatment Market, by Retail Pharmacies
10.2.3.10.8 France: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.10.8.1 France: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.10.8.2 France: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.11 UK
10.2.3.12 Overview
10.2.3.12.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.12.2 UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.12.3 UK: Malaria Treatment Market, by Treatment
10.2.3.12.4 UK: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.12.5 UK: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.12.6 UK: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.12.7 UK: Malaria Treatment Market, by Distribution Channel
10.2.3.12.7.1 UK: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.12.7.2 UK: Malaria Treatment Market, by Retail Pharmacies
10.2.3.12.8 UK: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.12.8.1 UK: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.12.8.2 UK: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.13 Italy
10.2.3.14 Overview
10.2.3.14.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.14.2 Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.14.3 Italy: Malaria Treatment Market, by Treatment
10.2.3.14.4 Italy: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.14.5 Italy: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.14.6 Italy: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.14.7 Italy: Malaria Treatment Market, by Distribution Channel
10.2.3.14.7.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.14.7.2 Italy: Malaria Treatment Market, by Retail Pharmacies
10.2.3.14.8 Italy: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.14.8.1 Italy: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.14.8.2 Italy: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.15 Germany
10.2.3.16 Overview
10.2.3.16.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.16.2 Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.16.3 Germany: Malaria Treatment Market, by Treatment
10.2.3.16.4 Germany: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.16.5 Germany: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.16.6 Germany: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.16.7 Germany: Malaria Treatment Market, by Distribution Channel
10.2.3.16.7.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.16.7.2 Germany: Malaria Treatment Market, by Retail Pharmacies
10.2.3.16.8 Germany: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.16.8.1 Germany: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.16.8.2 Germany: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.17 Spain
10.2.3.18 Overview
10.2.3.18.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.18.2 Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.18.3 Spain: Malaria Treatment Market, by Treatment
10.2.3.18.4 Spain: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.18.5 Spain: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.18.6 Spain: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.18.7 Spain: Malaria Treatment Market, by Distribution Channel
10.2.3.18.7.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.18.7.2 Spain: Malaria Treatment Market, by Retail Pharmacies
10.2.3.18.8 Spain: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.18.8.1 Spain: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.18.8.2 Spain: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.19 Rest of Europe
10.2.3.20 Overview
10.2.3.20.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.20.2 Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.20.3 Rest of Europe: Malaria Treatment Market, by Treatment
10.2.3.20.4 Rest of Europe: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.20.5 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.20.6 Rest of Europe: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.20.7 Rest of Europe: Malaria Treatment Market, by Distribution Channel
10.2.3.20.7.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.20.7.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.3.20.8 Rest of Europe: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.20.8.1 Rest of Europe: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.20.8.2 Rest of Europe: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3 Asia Pacific Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.3.1 Overview
10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.1 Asia Pacific: Malaria Treatment Market, by Treatment
10.3.3.2 Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.3 Asia Pacific: Malaria Treatment Market, by Route of Administration
10.3.3.4 Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.5 Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.3.5.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.5.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.3.6 Asia Pacific: Sickle Cell Treatment Market, by Distribution Channel
10.3.3.6.1 Asia Pacific: Sickle Cell Treatment Market, by Hospital Pharmacies
10.3.3.6.2 Asia Pacific: Sickle Cell Treatment Market, by Retail Pharmacies
10.3.3.7 Asia Pacific: Malaria Treatment Market, by Countries
10.3.3.8 Asia Pacific: Sickle Cell Disease Treatment Market, by Country
10.3.3.9 China
10.3.3.10 Overview
10.3.3.10.1 China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.10.2 China: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.10.3 China: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.10.4 China: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.10.4.1 China: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.10.4.2 China: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.11 Japan
10.3.3.12 Overview
10.3.3.12.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.12.2 Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.12.3 Japan: Malaria Treatment Market, by Treatment
10.3.3.12.4 Japan: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.12.5 Japan: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.12.6 Japan: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.12.7 Japan: Malaria Treatment Market, by Distribution Channel
10.3.3.12.7.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.12.7.2 Japan: Malaria Treatment Market, by Retail Pharmacies
10.3.3.12.8 Japan: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.12.8.1 Japan: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.12.8.2 Japan: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.13 India
10.3.3.14 Overview
10.3.3.14.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.14.2 India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.14.3 India: Malaria Treatment Market, by Treatment
10.3.3.14.4 India: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.14.5 India: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.14.6 India: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.14.7 India: Malaria Treatment Market, by Distribution Channel
10.3.3.14.7.1 India: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.14.7.2 India: Malaria Treatment Market, by Retail Pharmacies
10.3.3.14.8 India: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.14.8.1 India: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.14.8.2 India: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.15 South Korea
10.3.3.16 Overview
10.3.3.16.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.16.2 South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.16.3 South Korea: Malaria Treatment Market, by Treatment
10.3.3.16.4 South Korea: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.16.5 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.16.6 South Korea: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.16.7 South Korea: Malaria Treatment Market, by Distribution Channel
10.3.3.16.7.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.16.7.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
10.3.3.16.8 South Korea: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.16.8.1 South Korea: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.16.8.2 South Korea: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.17 Australia
10.3.3.18 Overview
10.3.3.18.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.18.2 Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.18.3 Australia: Malaria Treatment Market, by Treatment
10.3.3.18.4 Australia: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.18.5 Australia: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.18.6 Australia: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.18.7 Australia: Malaria Treatment Market, by Distribution Channel
10.3.3.18.7.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.18.7.2 Australia: Malaria Treatment Market, by Retail Pharmacies
10.3.3.18.8 Australia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.18.8.1 Australia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.18.8.2 Australia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.19 Rest of Asia Pacific
10.3.3.20 Overview
10.3.3.20.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.20.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.20.3 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
10.3.3.20.4 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.20.5 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.20.6 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.20.7 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.3.20.7.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.20.7.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.3.20.8 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.20.8.1 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.20.8.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4 Middle East & Africa Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.4.1 Overview
10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.1 Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.3.2 Middle East & Africa: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.3 Middle East & Africa: Malaria Treatment Market, by Route of Administration
10.4.3.4 Middle East & Africa: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.5 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.3.5.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.5.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.3.6 Middle East & Africa: Sickle Cell Treatment Market, by Distribution Channel
10.4.3.6.1 Middle East & Africa: Sickle Cell Treatment Market, by Hospital Pharmacies
10.4.3.6.2 Middle East & Africa: Sickle Cell Treatment Market, by Retail Pharmacies
10.4.3.7 Middle East & Africa: Malaria Treatment Market, by Country
10.4.3.8 Middle East & Africa: Sickle Cell Disease Treatment Market, by Country
10.4.3.9 Saudi Arabia
10.4.3.10 Overview
10.4.3.10.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.10.2 Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.10.3 Saudi Arabia: Malaria Treatment Market, by Treatment
10.4.3.10.4 Saudi Arabia: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.10.5 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.10.6 Saudi Arabia: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.10.7 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
10.4.3.10.7.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.10.7.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
10.4.3.10.8 Saudi Arabia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.10.8.1 Saudi Arabia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.10.8.2 Saudi Arabia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.11 UAE
10.4.3.12 Overview
10.4.3.12.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.12.2 UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.12.3 UAE: Malaria Treatment Market, by Treatment
10.4.3.12.4 UAE: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.12.5 UAE: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.12.6 UAE: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.12.7 UAE: Malaria Treatment Market, by Distribution Channel
10.4.3.12.7.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.12.7.2 UAE: Malaria Treatment Market, by Retail Pharmacies
10.4.3.12.8 UAE: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.12.8.1 UAE: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.12.8.2 UAE: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.13 South Africa
10.4.3.14 Overview
10.4.3.14.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.14.2 South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.14.3 South Africa: Malaria Treatment Market, by Treatment
10.4.3.14.4 South Africa: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.14.5 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.14.6 South Africa: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.14.7 South Africa: Malaria Treatment Market, by Distribution Channel
10.4.3.14.7.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.14.7.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.3.14.8 South Africa: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.14.8.1 South Africa: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.14.8.2 South Africa: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.15 Kenya
10.4.3.16 Overview
10.4.3.16.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.16.2 Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.16.3 Kenya: Malaria Treatment Market, by Treatment
10.4.3.16.4 Kenya: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.16.5 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.16.6 Kenya: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.16.7 Kenya: Malaria Treatment Market, by Distribution Channel
10.4.3.16.7.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.16.7.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
10.4.3.16.8 Kenya: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.16.8.1 Kenya: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.16.8.2 Kenya: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.17 Tanzania
10.4.3.18 Overview
10.4.3.18.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.18.2 Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.18.3 Tanzania: Malaria Treatment Market, by Treatment
10.4.3.18.4 Tanzania: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.18.5 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.18.6 Tanzania: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.18.7 Tanzania: Malaria Treatment Market, by Distribution Channel
10.4.3.18.7.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.18.7.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
10.4.3.18.8 Tanzania: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.18.8.1 Tanzania: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.18.8.2 Tanzania: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.19 Rwanda
10.4.3.20 Overview
10.4.3.20.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.20.2 Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.20.3 Rwanda: Malaria Treatment Market, by Treatment
10.4.3.20.4 Rwanda: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.20.5 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.20.6 Rwanda: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.20.7 Rwanda: Malaria Treatment Market, by Distribution Channel
10.4.3.20.7.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.20.7.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
10.4.3.20.8 Rwanda: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.20.8.1 Rwanda: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.20.8.2 Rwanda: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.21 Nigeria
10.4.3.22 Overview
10.4.3.22.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.22.2 Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.22.3 Nigeria: Malaria Treatment Market, by Treatment
10.4.3.22.4 Nigeria: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.22.5 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.22.6 Nigeria: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.22.7 Nigeria: Malaria Treatment Market, by Distribution Channel
10.4.3.22.7.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.22.7.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
10.4.3.22.8 Nigeria: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.22.8.1 Nigeria: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.22.8.2 Nigeria: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.23 Ghana
10.4.3.24 Overview
10.4.3.24.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.24.2 Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.24.3 Ghana: Malaria Treatment Market, by Treatment
10.4.3.24.4 Ghana: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.24.5 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.24.6 Ghana: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.24.7 Ghana: Malaria Treatment Market, by Distribution Channel
10.4.3.24.7.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.24.7.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
10.4.3.24.8 Ghana: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.24.8.1 Ghana: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.24.8.2 Ghana: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.25 Uganda
10.4.3.26 Overview
10.4.3.26.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.26.2 Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.26.3 Uganda: Malaria Treatment Market, by Treatment
10.4.3.26.4 Uganda: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.26.5 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.26.6 Uganda: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.26.7 Uganda: Malaria Treatment Market, by Distribution Channel
10.4.3.26.7.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.26.7.2 Uganda: Malaria Treatment Market, by Retail Pharmacies

Figure 1. PEST Analysis – Malaria
Figure 2. PEST Analysis – Sickle Cell Disease Treatment
Figure 3. Malaria and Sickle Cell Disease Treatment Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Malaria Treatment Market Revenue (US$ million), 2020 – 2030
Figure 6. Sickle Cell Disease Treatment Market Revenue (US$ million), 2020 – 2030
Figure 7. Malaria: Geography Analysis Market Revenue (US$ million), 2022 – 2030
Figure 8. Sickle Cell Disease: Geography Analysis Market Revenue (US$ million), 2022 – 2030
Figure 9. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 10. Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 11. Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 14. Sickle Cell Disease Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 15. Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Oral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parenteral: Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Parenteral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 20. Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 21. Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Direct Tender: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospital Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hospital Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Online Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Others: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 32. North America Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
Figure 33. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 36. North America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 37. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. US: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Canada: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Mexico: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 44. Europe Malaria and Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
Figure 45. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 48. Europe: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 49. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. France: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 51. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UK: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Italy: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Germany: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. Spain: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of Europe: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Malaria Treatment Market, 2022 ($Mn)
Figure 62. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 63. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 64. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 65. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 66. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 67. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 69. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 71. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 72. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 73. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 74. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 75. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 76. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 77. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 78. Malaria Treatment Market, 2022 (US$ Mn)
Figure 79. Sickle Cell Disease Treatment Market, 2022 (US$ Mn)
Figure 80. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 81. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 82. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 83. Middle East & Africa: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 84. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 85. Saudi Arabia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 86. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 87. UAE: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 88. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 89. South Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 90. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 91. Kenya: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 92. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 93. Tanzania: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 94. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 95. Rwanda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 96. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 97. Nigeria: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 98. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 99. Ghana: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 100. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 101. Uganda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 102. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 103. Angola: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 104. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 105. Cameroon: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 106. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 107. Senegal: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 108. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 109. Zambia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 110. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 111. Rest of Middle East & Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 112. Malaria Treatment Market, 2022 ($Mn)
Figure 113. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 114. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 115. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 116. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 117. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 118. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 119. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 120. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 121. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 122. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 123. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 124. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 125. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 126. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 127. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 128. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 129. Malaria Treatment Market, 2022 ($Mn)
Figure 130. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 131. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 132. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 133. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 134. South & Central America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 135. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 136. Brazil: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 137. Argentina: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 138. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 139. Rest of South & Central America: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 140. Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market